Corporate Magazine 2012 - Boehringer Ingelheim

OUR GLOBAL SCIENTIFIC NET WORKIN ANIMAL HEALTH1 fort dodge, usa2 ames, usa3 st. joseph, usa4 guadalajara, mexico5 ingelheim, germany6 hannover, germany7 tokyo, japan8 shanghai, china42316587INNOVATIVE VACCINES –MILESTONES IN SWINE HEALTHThis is a selection of the swinevaccines with which we inspirednew perspectives in animal healthmanagement.Healthy animals are the preconditionfor healthy meat. Any contributionto the well-being of farm animals istherefore also an important contributionto consumer protection.are working on innovative solutionsto best serve our customers. Unmetmedical needs are challenges for theresearchers and their ambition is tofind innovative and effective solutions.The numbers of newly emerging diseasesare expected to rise in an increasinglyglobalised economy and due toclimate change. Timely provision ofvaccines in response to these diseaseswill be a key factor in keeping animals,and thereby humans, healthy.Global manufacturing – focuson reliable supplyClose cooperation between our Operationsand Research and Development iscrucial in the supply chain. It usuallytakes 180 days to produce a vaccineproduct. As diseases and epidemics occurin waves, it is important to maintaindelivery at all times and have sufficientcapacity to react quickly. Our goal is areliable supply situation to be achievedin several stages.This year, we enlarged capacities in ourAnimal Health business. Acquisition of aproduction facility for vaccines in Weesp,the Netherlands, provides higher flexibilityfor manufacturing in Europe. Wealso invested at our other internationalmanufacturing sites, in state-of-the-arttechnology contributing to the needs ofour global, successful business.100 Boehringer Ingelheim annual report 2012